{
 "id": "EHACurriculumV2Part6",
 "label": {
  "en": "Default Base formlet in compound formlets",
  "sv": "Default formulet bas i sammansatta formuletter"
 },
 "description": {
  "en": "This is the formlet used as base in compound formlets by default. The formlets consists of a query with only a base variable and a minimal form specification. If the base formlet is not loaded (i.e. the containing formlet set) many compound formlets will break.",
  "sv": "Denna formuletten används som bas i många sammansatta formuletter som default. Formuletten består av en fråga med endast en basvariabel samt en minimal formulärspecifikation. Om denna basformulett inte är laddad (egentligen den omgivande formulett mängden) så kommer många sammansatta formuletter inte att fungera."
 },
 "root": {
  "nodetype": "RESOURCE",
  "label": {
   "de": "Ressource",
   "en": "Resource",
   "sv": "Resurs"
  },
  "@type": "group",
  "content": [
   {
    "styles": ["GroupFormItem"],
    "nodetype": "BLANK",
    "cardinality": {
     "min": 0,
     "pref": 1,
     "max": 1
    },
    "label": {"en": "6 THROMBOSIS AND HEMOSTASIS "},
    "@type": "group",
    "cls": ["rformsTable","rformsFirstcolumnfixedtable"],"property": "http://scam.sf.net/schema#hasCompetence",
    "description": {"en": "The practice of clinical hemostasis and thrombosis requires a combination of diagnostic laboratory and clinical expertise. As in other areas of clinical hematology there is a major overlap with general internal medicine. Therefore a holistic approach to disease management requires adequate training in general internal medicine as well as in hemostasis and thrombosis. "},
    "content": [
     {
      "styles": ["ChoiceFormItem"],
      "nodetype": "URI",
      "cardinality": {
       "min": 0,
       "pref": 1,
       "max": 1
      },
      "label": {"en": "6A: LABORATORY MANAGEMENT"},
      "@type": "choice",
      "cls":["rformsNoneditable"],"property": "http://scam.sf.net/schema#competencyDefinition",
      "choices": [
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6AA",
        "label": {"en": "a) Techniques for assessing coagulation and platelets"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6AB",
        "label": {"en": "b) Assays for inhibitors (incl. anti-phospholipid antibodies) "}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6AC",
        "label": {"en": "c) Establishing ranges, including relevance to gender and age"}
       }
      ]
     },
     {
      "styles": ["ChoiceFormItem"],
      "nodetype": "URI",
      "cardinality": {
       "min": 0,
       "pref": 1,
       "max": 1
      },
      "label": {"en": "Level"},
      "@type": "choice",
      "property": "http://scam.sf.net/schema#competenceLevel",
      "choices": [
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#CompetenceLevel1",
        "label": {"en": "1"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#CompetenceLevel2",
        "label": {"en": "2"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#CompetenceLevel3",
        "label": {"en": "3"}
       }
      ]
     }
    ],
    "constraints": {"http://purl.org/dc/terms/type": "http://www.ehaweb.org/rdf/2011-passport#LaboratoryManagement"}
   },
   {
    "styles": ["GroupFormItem"],
    "nodetype": "BLANK",
    "cardinality": {
     "min": 0,
     "pref": 1,
     "max": 1
    },
    "label": {"en": ""},
    "@type": "group",
    "cls": ["rformsTable","rformsFirstcolumnfixedtable"],"property": "http://scam.sf.net/schema#hasCompetence",
    "content": [
     {
      "styles": ["ChoiceFormItem"],
      "nodetype": "URI",
      "cardinality": {
       "min": 0,
       "pref": 1,
       "max": 1
      },
      "label": {"en": "6B: ACQUIRED BLEEDING DISORDERS "},
      "@type": "choice",
      "cls":["rformsNoneditable"],"property": "http://scam.sf.net/schema#competencyDefinition",
      "choices": [
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6BA",
        "label": {"en": "a) Massive bleeding in obstetrics, trauma and surgery"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6BB",
        "label": {"en": "b) Disseminated intravascular coagulation (DIC)"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6BC",
        "label": {"en": "c) Bleeding associated with renal and liver disease"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6BD",
        "label": {"en": "d) Bleeding related to anticoagulants and antithrombotic therapy"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6BE",
        "label": {"en": "e) Acquired bleeding disorders in adults (inhibitors to F VIII and vWF)"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6BF",
        "label": {"en": "f) Acquired bleeding disorders in children"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6BG",
        "label": {"": "g) Adverse effects of treatment used in acute bleeding (blood products, pro-haemostatic drugs  ) "}
       }
      ]
     },
     {
      "styles": ["ChoiceFormItem"],
      "nodetype": "URI",
      "cardinality": {
       "min": 0,
       "pref": 1,
       "max": 1
      },
      "label": {"en": "Level"},
      "@type": "choice",
      "property": "http://scam.sf.net/schema#competenceLevel",
      "choices": [
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#CompetenceLevel1",
        "label": {"": "1"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#CompetenceLevel2",
        "label": {"": "2"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#CompetenceLevel3",
        "label": {"": "3"}
       }
      ]
     }
    ],
    "constraints": {"http://purl.org/dc/terms/type": "http://www.ehaweb.org/rdf/2011-passport#AcquiredBleedingDisorders"}
   },
   {
    "styles": ["GroupFormItem"],
    "nodetype": "BLANK",
    "cardinality": {
     "min": 0,
     "pref": 1,
     "max": 1
    },
    "@type": "group",
    "cls": ["rformsTable","rformsFirstcolumnfixedtable"],"property": "http://scam.sf.net/schema#hasCompetence",
    "content": [
     {
      "styles": ["ChoiceFormItem"],
      "nodetype": "URI",
      "cardinality": {
       "min": 0,
       "pref": 1,
       "max": 1
      },
      "label": {"en": "6C: CONGENITAL BLEEDING DISORDERS "},
      "@type": "choice",
      "cls":["rformsNoneditable"],"property": "http://scam.sf.net/schema#competencyDefinition",
      "choices": [
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6CA",
        "label": {"en": "a)  Mechanisms in hemostasis"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6CB",
        "label": {"en": "b) Taking a relevant bleeding history (previous challenges and family history) with a focused clinical examination "}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6CC",
        "label": {"en": "c) Hemophilia A & B"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6CD",
        "label": {"en": "d) Von Willebrand’s disease"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6CE",
        "label": {"en": "e) Other bleeding disorders (e.g. deficiency of factor XIII,  XI, X, VII, V and II, and hypofibrinogenaemia)"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6CF",
        "label": {"en": "f) Considerations in carriers of hemophilia in relation to pregnancy and management of neonates with hemophilia "}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6CG",
        "label": {"en": "g) Safety of treatment with blood products and factor concentrates "}
       }
      ]
     },
     {
      "styles": ["ChoiceFormItem"],
      "nodetype": "URI",
      "cardinality": {
       "min": 0,
       "pref": 1,
       "max": 1
      },
      "label": {"en": "Level"},
      "@type": "choice",
      "property": "http://scam.sf.net/schema#competenceLevel",
      "choices": [
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#CompetenceLevel1",
        "label": {"en": "1"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#CompetenceLevel2",
        "label": {"en": "2"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#CompetenceLevel3",
        "label": {"en": "3"}
       }
      ]
     }
    ],
    "constraints": {"http://purl.org/dc/terms/type": "http://www.ehaweb.org/rdf/2011-passport#CongenitalBleedingDisorders"}
   },
   {
    "styles": ["GroupFormItem"],
    "nodetype": "BLANK",
    "cardinality": {
     "min": 0,
     "pref": 1,
     "max": 1
    },
    "@type": "group",
    "cls": ["rformsTable","rformsFirstcolumnfixedtable"],"property": "http://scam.sf.net/schema#hasCompetence",
    "content": [
     {
      "styles": ["ChoiceFormItem"],
      "nodetype": "URI",
      "cardinality": {
       "min": 0,
       "pref": 1,
       "max": 1
      },
      "label": {"en": "6D: PLATELET DISORDERS "},
      "@type": "choice",
      "cls":["rformsNoneditable"],"property": "http://scam.sf.net/schema#competencyDefinition",
      "choices": [
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6DA",
        "label": {"en": "a) Platelet structure, function and vessel wall interactions"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6DB",
        "label": {"en": "b) Congenital platelet disorders, (e.g. Bernard-Soulier syndrome)"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6DC",
        "label": {"en": "c) Heparin-induced thrombocytopenia"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6DD",
        "label": {"": "d) Thrombocytopenia in pregnancy "}
       }
      ]
     },
     {
      "styles": ["ChoiceFormItem"],
      "nodetype": "URI",
      "cardinality": {
       "min": 0,
       "pref": 1,
       "max": 1
      },
      "label": {"en": "Level"},
      "@type": "choice",
      "property": "http://scam.sf.net/schema#competenceLevel",
      "choices": [
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#CompetenceLevel1",
        "label": {"en": "1"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#CompetenceLevel2",
        "label": {"en": "2"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#CompetenceLevel3",
        "label": {"en": "3"}
       }
      ]
     }
    ],
    "constraints": {"http://purl.org/dc/terms/type": "http://www.ehaweb.org/rdf/2011-passport#PlateletDisorders"}
   },
   {
    "styles": ["GroupFormItem"],
    "nodetype": "BLANK",
    "cardinality": {
     "min": 0,
     "pref": 1,
     "max": 1
    },
    "@type": "group",
    "cls": ["rformsTable","rformsFirstcolumnfixedtable"],"property": "http://scam.sf.net/schema#hasCompetence",
    "content": [
     {
      "styles": ["ChoiceFormItem"],
      "nodetype": "URI",
      "cardinality": {
       "min": 0,
       "pref": 1,
       "max": 1
      },
      "label": {"en": "6E:  THROMBOTIC DISORDERS"},
      "@type": "choice",
      "cls":["rformsNoneditable"],"property": "http://scam.sf.net/schema#competencyDefinition",
      "choices": [
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6EA",
        "label": {"en": "a) Mechanisms and risk-factors in arterial and venous thromboembolism"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6EB",
        "label": {"en": "b) Venous thromboembolism "}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6EC",
        "label": {"en": "c) Laboratory monitoring and dosing of anticoagulants"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6ED",
        "label": {"en": "d) Post-thrombotic complications"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6EE",
        "label": {"en": "e) Thrombophilia (e.g. F V Leiden, II G20210A)"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6EF",
        "label": {"en": "f) Acquired thrombotic tendency, (e.g. APS, HIT, PNH and MPN)"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6EG",
        "label": {"en": "g) Treatment and prophylaxis  of venous thromboembolism in pregnancy"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6EH",
        "label": {"en": "h) Specific therapy in thrombotic disorders (e.g. caval filters) "}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6EI",
        "label": {"en": "i) Purpura fulminans"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#Item6EJ",
        "label": {"en": "j) Adverse drug reactions to anticoagulant, antiplatelet and thrombolytic therapy"}
       }
      ]
     },
     {
      "styles": ["ChoiceFormItem"],
      "nodetype": "URI",
      "cardinality": {
       "min": 0,
       "pref": 1,
       "max": 1
      },
      "label": {"en": "Level"},
      "@type": "choice",
      "property": "http://scam.sf.net/schema#competenceLevel",
      "choices": [
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#CompetenceLevel1",
        "label": {"en": "1"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#CompetenceLevel2",
        "label": {"en": "2"}
       },
       {
        "value": "http://www.ehaweb.org/rdf/2011-passport#CompetenceLevel3",
        "label": {"en": "3"}
       }
      ]
     }
    ],
    "constraints": {"http://purl.org/dc/terms/type": "http://www.ehaweb.org/rdf/2011-passport#GeneticsAndMolecularBiology"}
   }
  ]
 }
}
